BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7492439)

  • 1. Cytokine-containing liposomes as adjuvants for HIV subunit vaccines.
    Lachman LB; Shih LC; Rao XM; Hu X; Bucana CD; Ullrich SE; Cleland JL
    AIDS Res Hum Retroviruses; 1995 Aug; 11(8):921-32. PubMed ID: 7492439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoliposomes containing antibodies to costimulatory molecules as adjuvants for HIV subunit vaccines.
    Ozpolat B; Rao XM; Powell MF; Lachman LB
    AIDS Res Hum Retroviruses; 1998 Mar; 14(5):409-17. PubMed ID: 9546800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
    Gorse GJ; Corey L; Patel GB; Mandava M; Hsieh RH; Matthews TJ; Walker MC; McElrath MJ; Berman PW; Eibl MM; Belshe RB
    AIDS Res Hum Retroviruses; 1999 Jan; 15(2):115-32. PubMed ID: 10029244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a single-shot subunit vaccine for HIV-1.
    Cleland JL; Powell MF; Lim A; Barrón L; Berman PW; Eastman DJ; Nunberg JH; Wrin T; Vennari JC
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S21-6. PubMed ID: 7865303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and function of HIV-1 CRF01_AE envelope proteins from blood and genital fluid isolates.
    Horthongkham N; Athipanyasilp N; Siritantikorn S; Kantakamalakul W; Srisurapanon S; Sutthent R
    Southeast Asian J Trop Med Public Health; 2009 May; 40(3):480-93. PubMed ID: 19842433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-gamma antibody.
    Toda S; Ishii N; Okada E; Kusakabe KI; Arai H; Hamajima K; Gorai I; Nishioka K; Okuda K
    Immunology; 1997 Sep; 92(1):111-7. PubMed ID: 9370932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MN and IIIB recombinant glycoprotein 120 vaccine-induced binding antibodies to native envelope glycoprotein of human immunodeficiency virus type 1 primary isolates. National Institute of Allergy and Infectious Disease Aids Vaccine Evaluation Group.
    Gorse GJ; Patel GB; Mandava M; Berman PW; Belshe RB
    AIDS Res Hum Retroviruses; 1999 Jul; 15(10):921-30. PubMed ID: 10408729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant effects on morphine-induced suppression of immune responses to MN rgp120/HIV-1 in mice.
    Virsik PA; Bussiere JL
    Adv Exp Med Biol; 1995; 373():183-8. PubMed ID: 7668150
    [No Abstract]   [Full Text] [Related]  

  • 10. Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120.
    Jankovic D; Caspar P; Zweig M; Garcia-Moll M; Showalter SD; Vogel FR; Sher A
    J Immunol; 1997 Sep; 159(5):2409-17. PubMed ID: 9278332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.
    Garzón MR; Berraondo P; Crettaz J; Ochoa L; Vera M; Lasarte JJ; Vales A; Van Rooijen N; Ruiz J; Prieto J; Zulueta J; González-Aseguinolaza G
    Vaccine; 2005 Feb; 23(11):1384-92. PubMed ID: 15661387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG2 inhibits HIV-1 internalization by monocytes, and IgG subclass binding is affected by gp120 glycosylation.
    Forthal DN; Landucci G; Ding H; Kappes JC; Wang A; Thung I; Phan T
    AIDS; 2011 Nov; 25(17):2099-104. PubMed ID: 21832933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a single-shot subunit vaccine for HIV-1. 5. programmable in vivo autoboost and long lasting neutralizing response.
    Cleland JL; Lim A; Daugherty A; Barron L; Desjardin N; Duenas ET; Eastman DJ; Vennari JC; Wrin T; Berman P; Murthy KK; Powell MF
    J Pharm Sci; 1998 Dec; 87(12):1489-95. PubMed ID: 10189254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120.
    AIDS Vaccine Evaluation Group 022 Protocol Team
    J Infect Dis; 2001 Feb; 183(4):563-70. PubMed ID: 11170981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1.
    Prohászka Z; Hidvégi T; Ujhelyi E; Stoiber H; Dierich MP; Süsal C; Füst G
    Immunology; 1995 Jun; 85(2):184-9. PubMed ID: 7642209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sendai virus-based production of HIV type 1 subtype B and subtype E envelope glycoprotein 120 antigens and their use for highly sensitive detection of subtype-specific serum antibodies.
    Toriyoshi H; Shioda T; Sato H; Sakaguchi M; Eda Y; Tokiyoshi S; Kato K; Nohtomi K; Kusagawa S; Taniguchi K; Shiino T; Kato A; Foongladda S; Linkanonsakul S; Oka SI; Iwamoto A; Wasi C; Nagai Y; Takebe Y
    AIDS Res Hum Retroviruses; 1999 Aug; 15(12):1109-20. PubMed ID: 10461831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice.
    Shinoda K; Xin KQ; Jounai N; Kojima Y; Tamura Y; Okada E; Kawamoto S; Okuda K; Klinman D; Okuda K
    Vaccine; 2004 Sep; 22(27-28):3676-90. PubMed ID: 15315847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmid immunization primes unique DTH responses to HIV-1MN envelope epitopes as compared to recombinant protein vaccination.
    Chattergoon MA; Maguire HH; Robinson TM; Serrano E; Boyer JD; Weiner DB
    Hybrid Hybridomics; 2002 Apr; 21(2):117-22. PubMed ID: 12031101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses against a new HIV-1 p24-gp41/pCAGGS-IL-12 DNA vaccine in Balb/c mice.
    Roodbari F; Sabahi F; Sarbolouki MN; Barkhordari F; Adeli A; Jamedar A; Mahboudi F
    Iran J Immunol; 2012 Jun; 9(2):86-97. PubMed ID: 22735796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.